Mark M. Goodman, PhD

Arriving at Emory in 1993, Dr. Goodman is Professor of Radiology and Imaging Sciences, Psychiatry and Hematology and Oncology Tracer Development At Emory University School of Medicine and Program Director of the Emory Center for Systems Imaging and Director of the Radiopharmaceutical Discovery Lab.

After working as a chemist at Roswell Park Cancer Institute, Dr. Goodman joined the Department of Radiology at Harvard University in 1978 to pursue the development of positron emitting carbohydrates and fatty acids. In fall 1980, he took a position as a staff scientist at Oak Ridge National Laboratory and worked on the development of single photon labeled fatty acids and carbohydrates. Dr. Goodman's research led to the development of the methylbranched fatty acid [123I] BMIPP, which has been commercially introduced in Japan as Cardiodine. In 1987, Dr. Goodman moved to the University of Tennessee Medical Center at Knoxville where he took the position of Associate Professor of Radiology and Director of Radiopharmaceutical Chemistry to help establish the University of Tennessee PET program. At the University of Tennessee, he developed the dopamine transporter imaging agents [18F] FPCT, [123I] MMG-142/IPT and translated [11C] ACBC to image brain tumors in humans. He was promoted to Professor of Radiology in 1993.